Related references
Note: Only part of the references are listed.Sirtuin 6 nuclear localization at cortical brain level of young diabetic mice: An immunohistochemical study
Gaia Favero et al.
ACTA HISTOCHEMICA (2014)
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
Yanmei Zeng et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
M. Barbieri et al.
ATHEROSCLEROSIS (2013)
The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Jean-Pierre Etchegaray et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials
M. Monami et al.
DIABETES OBESITY & METABOLISM (2013)
Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?
M. Burgmaier et al.
DIABETIC MEDICINE (2013)
Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation
M. L. Balestrieri et al.
DIABETOLOGIA (2013)
Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways
Ozlem Erdogdu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Sirtuin 6: a review of biological effects and potential therapeutic properties
Jade M. Beauharnois et al.
MOLECULAR BIOSYSTEMS (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe -/- mice
F. Vittone et al.
DIABETOLOGIA (2012)
Endothelial progenitor cells in atherosclerosis
Fuyong Du et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Sitagliptin Exerts an Antinflammatory Action
Antoine Makdissi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Exenatide Exerts a Potent Antiinflammatory Effect
Ajay Chaudhuri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice
Junichi Matsubara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun
Nagalingam R. Sundaresan et al.
NATURE MEDICINE (2012)
Anti-Inflammatory Properties of Sirtuin 6 in Human Umbilical Vein Endothelial Cells
Martha Lappas
MEDIATORS OF INFLAMMATION (2012)
Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice
Jinmi Lee et al.
PLOS ONE (2012)
Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses
Rachel Grimley et al.
PLOS ONE (2012)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
SIRT6 protects against pathological damage caused by diet-induced obesity
Yariv Kanfi et al.
AGING CELL (2010)
Endothelial progenitor cells express PAF receptor and respond to PAF via Ca2+-dependent signaling
Maria Luisa Balestrieri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Hepatic-Specific Disruption of SIRT6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride Synthesis
Hyun-Seok Kim et al.
CELL METABOLISM (2010)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span
Tiara L. A. Kawahara et al.
CELL (2009)
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Etie S. Moghissi et al.
DIABETES CARE (2009)
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Eriko Michishita et al.
NATURE (2008)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque - Effects of rosiglitazone treatment
Raffaele Marfella et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques - Effects of rosiglitazone treatment
R Marfella et al.
DIABETES (2006)
Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins
E Michishita et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke
LG Spagnoli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
MA Creager et al.
CIRCULATION (2003)
Share Paper
